Loading...
DocGo Inc (DCGO) is not a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock exhibits a bearish technical trend, poor financial performance, and lacks positive catalysts or strong trading signals. Additionally, the absence of recent news, weak sentiment from options data, and no significant insider or hedge fund activity further diminish its appeal.
The stock is in a bearish trend with MACD below 0 and negatively expanding, RSI at 38.482 (neutral zone), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support is at 0.678, and resistance is at 0.734. The stock closed at 0.6993, below the pivot point, indicating further downside potential.

NULL identified. No recent news, no significant insider or hedge fund activity, and no recent congress trading data.
The company's financials for Q3 2025 show a significant decline in revenue (-48.94% YoY), net income (-605.07% YoY), EPS (-660.00% YoY), and gross margin (-39.39% YoY). The stock also lacks positive trading signals and exhibits a bearish technical trend.
In Q3 2025, the company reported a revenue drop to $70.81M (-48.94% YoY), a net income loss of $27.77M (-605.07% YoY), and an EPS of -0.28 (-660.00% YoY). Gross margin also declined to 19.99% (-39.39% YoY), indicating deteriorating profitability.
No recent analyst ratings or price target changes are available for this stock.